Etanercept biosimilar (Reliance Life Sciences)

依那西普生物类似药（Reliance Life Sciences）

Report date: 2024/06/27 15:16:26

Base Information

Drug NameEtanercept biosimilar (Reliance Life Sciences)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion proteinBiologics > Biosimilar
Mechanisms of ActionTumor necrosis factor α inhibitorsTumor necrosis factor β inhibitors
TargetsTumor necrosis factor αTumor necrosis factor β
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesReliance Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesReliance Life Sciences
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A